Key result
Higher Lp(a) levels linked to ~31% higher odds of OCT-defined high-risk coronary plaques.
Why the study?
The relationship between circulating Lipoprotein(a) levels and coronary plaque morphology assessed by optical coherence tomography remains incompletely characterized.
Does increasing circulating Lipoprotein(a) associate with high-risk coronary plaque phenotypes on OCT in patients undergoing intracoronary imaging?
Observational (n=50)
No
Does increasing circulating Lipoprotein(a) associate with high-risk coronary plaque phenotypes on OCT in patients undergoing intracoronary imaging?
Answers are grounded in this paper and cite their sources.
Elevated Lipoprotein(a) levels are significantly associated with OCT-defined vulnerable plaque phenotypes, supporting a mechanistic link between Lp(a) and coronary plaque instability.
BACKGROUND Lipoprotein(a) [Lp(a)] is a causal risk factor for coronary artery disease, but its relationship with coronary plaque morphology assessed by optical coherence tomography (OCT) remains incompletely characterized. OBJECTIVE To investigate the association between circulating Lp(a) levels and OCT-defined coronary plaque phenotypes using a comprehensive segment-level approach. METHODS In this prospective single-center study (RELACS registry; NCT05496790), consecutive patients undergoing intracoronary OCT with available Lp(a) measurements were included. Coronary vessels were divided into 3 mm segments and analyzed for plaque characteristics. Lp(a) was primarily modeled as a continuous variable to assess its association with OCT-defined plaque phenotypes, including high-risk, layered, and fibrous plaques. High-risk plaque was defined as the presence of ≥2 criteria between lipid-rich plaque, thin-cap fibroatheroma (TCFA), and macrophages. Mixed-effects logistic regression models were used to account for within-patient clustering. RESULTS A total of 952 coronary segments from 50 patients were analyzed. Increasing Lp(a) levels were significantly associated with multiple features of plaque vulnerability, including TCFA, lipid-rich plaques, macrophages, and microchannels. In the multivariate mixed-effects analysis, higher Lp(a) levels were independently associated with a greater likelihood of high-risk plaque (odds ratios [OR] 1.31, 95% CI 1.16-1.48; P < .001) and layered plaques (OR 1.15, 95% CI 1.02-1.29; P = .024), whereas an inverse association was observed with fibrous plaques (OR 0.84, 95% CI 0.70-1.00; P = .047). CONCLUSION Increasing Lp(a) levels were associated with OCT-defined coronary plaque phenotypes related to vulnerability and instability, including high-risk and layered plaques. Given the limited patient-level sample size, these findings should be considered exploratory and hypothesis-generating.
No takes yet. Share an insight, caveat, or question.
Acerbo et al. (2026) conducted an observational in Coronary artery disease (n=50). Circulating Lipoprotein(a) levels vs. Lower Lipoprotein(a) levels was evaluated on Likelihood of high-risk plaque (OR 1.31, 95% CI 1.16-1.48, p=< .001). Higher Lipoprotein(a) levels were independently associated with a greater likelihood of OCT-defined high-risk coronary plaques.
Synapse has enriched 10 related papers. Consider them for comparative context: